Menu
GeneBe

CR2

complement C3d receptor 2, the group of CD molecules|Sushi domain containing|Complement system regulators and receptors

Basic information

Region (hg38): 1:207453023-207489895

Links

ENSG00000117322NCBI:1380OMIM:120650HGNC:2336Uniprot:P20023AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • immunodeficiency, common variable, 7 (Moderate), mode of inheritance: AR
  • common variable immunodeficiency (Supportive), mode of inheritance: AD
  • immunodeficiency, common variable, 7 (Strong), mode of inheritance: AR
  • immunodeficiency, common variable, 7 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Common variable immune deficiency, 7ARAllergy/Immunology/InfectiousAntiinfectious prophylaxis and early and aggressive treatment of infections may be beneficialAllergy/Immunology/Infectious22035880

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CR2 gene.

  • Immunodeficiency, common variable, 7 (612 variants)
  • not provided (74 variants)
  • Inborn genetic diseases (48 variants)
  • not specified (13 variants)
  • CR2-related condition (11 variants)
  • Systemic lupus erythematosus, susceptibility to, 9;Immunodeficiency, common variable, 7 (7 variants)
  • Systemic lupus erythematosus, susceptibility to, 9;Immunodeficiency, common variable, 7;Immunodeficiency, common variable, 2 (3 variants)
  • Immunodeficiency, common variable, 7;Systemic lupus erythematosus, susceptibility to, 9 (3 variants)
  • Immunodeficiency, common variable, 7;Systemic lupus erythematosus, susceptibility to, 9;Immunodeficiency, common variable, 2 (2 variants)
  • Immunodeficiency, common variable, 2;Systemic lupus erythematosus, susceptibility to, 9;Immunodeficiency, common variable, 7 (1 variants)
  • Immunodeficiency, common variable, 2 (1 variants)
  • Immunodeficiency, common variable, 2;Immunodeficiency, common variable, 7;Systemic lupus erythematosus, susceptibility to, 9 (1 variants)
  • CR2-Related Disorders (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
122
clinvar
9
clinvar
135
missense
2
clinvar
332
clinvar
17
clinvar
8
clinvar
359
nonsense
12
clinvar
2
clinvar
14
start loss
0
frameshift
14
clinvar
3
clinvar
2
clinvar
19
inframe indel
3
clinvar
3
splice donor/acceptor (+/-2bp)
2
clinvar
6
clinvar
8
splice region
14
14
3
31
non coding
6
clinvar
47
clinvar
25
clinvar
78
Total 28 13 347 186 42

Highest pathogenic variant AF is 0.0000526

Variants in CR2

This is a list of pathogenic ClinVar variants found in the CR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-207454348-T-C Immunodeficiency, common variable, 7 Benign (Dec 22, 2023)478828
1-207454425-G-T Immunodeficiency, common variable, 7 Uncertain significance (Nov 27, 2023)577887
1-207454427-C-T Immunodeficiency, common variable, 7 Likely benign (Feb 01, 2024)1945610
1-207454430-G-A Immunodeficiency, common variable, 7 Likely benign (Dec 02, 2023)1020345
1-207454439-C-T Immunodeficiency, common variable, 7 • CR2-related disorder Likely benign (Oct 23, 2023)1149460
1-207454450-T-C Immunodeficiency, common variable, 7 Uncertain significance (Oct 04, 2022)1418007
1-207454457-C-G Immunodeficiency, common variable, 7 Likely benign (Dec 26, 2023)2783859
1-207454457-C-CG Immunodeficiency, common variable, 7 Pathogenic (Dec 31, 2022)2781409
1-207454458-G-C Immunodeficiency, common variable, 7 Uncertain significance (Nov 14, 2019)969353
1-207454460-C-T Immunodeficiency, common variable, 7 Likely benign (Apr 22, 2023)2786041
1-207454470-G-A Immunodeficiency, common variable, 7 Uncertain significance (Nov 27, 2018)540310
1-207454472-C-T Immunodeficiency, common variable, 7 Likely benign (Mar 15, 2022)2112836
1-207454488-G-C Immunodeficiency, common variable, 7 Likely benign (Jun 19, 2021)1567221
1-207454489-G-A Immunodeficiency, common variable, 7 Benign (Jan 25, 2024)1168459
1-207454489-G-T Immunodeficiency, common variable, 7 Likely benign (Sep 28, 2022)2101182
1-207454495-C-T Immunodeficiency, common variable, 7 Uncertain significance (Nov 27, 2021)1489151
1-207454573-G-A Immunodeficiency, common variable, 7 Benign (Jan 19, 2024)1166837
1-207466350-C-G Benign (Nov 10, 2018)1226449
1-207466506-G-A Immunodeficiency, common variable, 7 Likely benign (Nov 23, 2022)1653334
1-207466509-C-T Immunodeficiency, common variable, 7 Likely benign (Jul 19, 2023)1590611
1-207466513-T-C Immunodeficiency, common variable, 7 Likely benign (May 24, 2022)1902455
1-207466514-T-G Immunodeficiency, common variable, 7 Likely benign (Jun 20, 2022)1577061
1-207466516-T-C Immunodeficiency, common variable, 7 Likely benign (Dec 28, 2023)1611796
1-207466518-C-T Immunodeficiency, common variable, 7 Likely benign (Nov 10, 2020)725664
1-207466521-T-C Immunodeficiency, common variable, 7 Uncertain significance (May 12, 2022)2018054

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CR2protein_codingprotein_codingENST00000367057 1935666
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.74e-190.8781256520941257460.000374
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7935425970.9090.00003157113
Missense in Polyphen155192.610.804742351
Synonymous-0.5492212111.050.00001122151
Loss of Function2.293856.60.6710.00000334660

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005130.000510
Ashkenazi Jewish0.00009970.0000992
East Asian0.001410.00141
Finnish0.000.00
European (Non-Finnish)0.0004050.000404
Middle Eastern0.001410.00141
South Asian0.0002290.000229
Other0.0003280.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU (PubMed:7753047). Participates in B lymphocytes activation (PubMed:7753047). {ECO:0000269|PubMed:7753047}.;
Disease
DISEASE: Immunodeficiency, common variable, 7 (CVID7) [MIM:614699]: A primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen. The defect results from a failure of B-cell differentiation and impaired secretion of immunoglobulins; the numbers of circulating B-cells is usually in the normal range, but can be low. {ECO:0000269|PubMed:22035880}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Complement and coagulation cascades - Homo sapiens (human);B cell receptor signaling pathway - Homo sapiens (human);Hematopoietic cell lineage - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);B Cell Receptor Signaling Pathway;Human Complement System;Dengue-2 Interactions with Complement and Coagulation Cascades;Oxidative Damage;Complement and Coagulation Cascades;Innate Immune System;Immune System;BCR;Regulation of Complement cascade;Complement cascade (Consensus)

Recessive Scores

pRec
0.458

Intolerance Scores

loftool
0.952
rvis_EVS
0.06
rvis_percentile_EVS
57.56

Haploinsufficiency Scores

pHI
0.134
hipred
N
hipred_score
0.291
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.558

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Cr2
Phenotype
homeostasis/metabolism phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;

Gene ontology

Biological process
complement receptor mediated signaling pathway;immune response;complement activation, classical pathway;B cell differentiation;regulation of complement activation;B cell proliferation;innate immune response;viral entry into host cell
Cellular component
plasma membrane;integral component of membrane;receptor complex;extracellular exosome
Molecular function
virus receptor activity;complement binding;DNA binding;complement receptor activity;transmembrane signaling receptor activity;protein binding;protein homodimerization activity